Immunol Res. 2015 Jun;62(2):129-36. doi: 10.1007/s12026-015-8643-3.

中文速读

在桥本甲状腺炎患者外周血单个核细胞和甲状腺组织中,miR-125a-3p表达降低导致IL-23R上调,可能参与疾病发病机制。

体外(细胞)miRNAperipheral blood mononuclearthyroid tissues

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

Decreased expression of microRNA-125a-3p upregulates interleukin-23 receptor in patients with Hashimoto’s thyroiditis.

Peng H1, Liu Y, Tian J, Ma J, Tang X, Yang J, Rui K, Zhang Y, Mao C, Lu L, Xu H, Wang S.

Author information

1Department of Laboratory Medicine, The Affiliated People’s Hospital, Jiangsu University, Zhenjiang, 212002, Jiangsu Province, China.

Abstract

Interleukin IL-23 receptor (IL-23R) is increasingly recognized as a key checkpoint in autoimmune diseases, including Hashimoto’s thyroiditis (HT). However, the molecular mechanisms regulating IL-23R expression are still unknown. MicroRNAs have emerged as key regulators of various biological events via suppressing target mRNAs at the posttranscriptional level. In this study, we found that the IL-23R mRNA expression was increased in peripheral blood mononuclear cells from HT patients, and there was a positive correlation between the level of IL-23R mRNA and the serum level of anti-thyroglobulin antibody (TgAb). The miR-125a-3p expression was decreased and inversely correlated with elevated level of IL-23R in patients with HT. MiR-125a-3p inhibited IL-23R expression through directly targeting 3’untranslated region of IL-23R. An inverse correlation was observed between the level of miR-125a-3p and serum level of TgAb. Furthermore, we also found upregulated IL-23R expression and downregulated miR-125a-3p expression in thyroid tissues from HT patients. Taken together, our results indicate that decreased expression of miR-125a-3p was involved in the pathogenesis of Hashimoto’s thyroiditis.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单